Cite
MLA Citation
Irvin M. Modlin et al.. “Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy.” Annals of surgery, vol. 274, no. 3, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100146089265.0x000042